Kidney Research and Clinical Practice

Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial: Eun Jeong Ko, Mi-Sun Byun, Chul Woo Yang et al.; Kidney Res Clin Pract. 2026;45(5):778-791. Published online July 8, 2026; DOI: https://doi.org/10.23876/j.krcp.26.080; Full text PubReader ePub PDF Supplementary Material

Once-monthly darbepoetin alfa is non-inferior to biweekly dosing for maintaining target hemoglobin in erythropoiesis-stimulating agent-responsive Korean patients with non-dialysis chronic kidney disease: a multicenter phase 4 study: Jung Eun Lee, Byoung-Geun Han, Jong Hyun Jhee, Hyeong Cheon Park, Hoon Young Choi; Received June 16, 2025 Accepted February 2, 2026 Published online May 11, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Early hemoglobin levels after kidney transplantation predict clinical outcomes: Min-Gyu Kim, You Hyun Jeon, Jae Berm Park et al.; Received July 9, 2025 Accepted December 19, 2025 Published online March 6, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Ferric citrate for iron deficiency anemia in non-dialysis dependent chronic kidney disease: a randomized phase III study: Mei-Yi Wu, Chin-Chan Lee, Chien-Te Lee et al.; Received May 19, 2025 Accepted November 24, 2025 Published online January 21, 2026; [Epub ahead of print]
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Frailty-related factors and 1-year renal function change after sodium-glucose cotransporter-2 inhibitors in elderly chronic kidney disease patients: Hye-Mi Noh, Sei Hong Min, Hyung-Seok Lee, Sung Gyun Kim, Jun Goo Kang, Jwa-Kyung Kim; Kidney Res Clin Pract. 2026;45(5):713-723. Published online December 8, 2025; DOI: https://doi.org/10.23876/j.krcp.25.110; Full text PubReader ePub PDF Supplementary Material

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis: Geo Neul Park, Kyung Ho Lee, Ji Eun Moon et al.; Kidney Res Clin Pract. 2024;43(3):369-380. Published online January 23, 2024; DOI: https://doi.org/10.23876/j.krcp.23.074
Web of Science 2 Cited By 3; Full text PubReader ePub PDF Supplementary Material

Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?: Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin; Kidney Res Clin Pract. 2023;42(1):27-38. Published online November 21, 2022; DOI: https://doi.org/10.23876/j.krcp.22.118
Web of Science 6 Cited By 7; Full text PubReader ePub PDF

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up: Antonio Lacquaniti, Patrizio Pasqualetti, Teresa Casuscelli di Tocco et al.; Kidney Res Clin Pract. 2020;39(3):334-343. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.015
Web of Science 10 Cited By 11; Full text PubReader PDF

Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: cross sectional analysis of real-world data: Heleen van Haalen, James Sloand, Rebecca Moon et al.; Kidney Res Clin Pract. 2020;39(3):318-333. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.020
Web of Science 8 Cited By 9; Full text PubReader PDF

Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients: Yu Ho Lee, Yoon Soo Shin, So-Young Lee et al.; Kidney Res Clin Pract. 2020;39(1):103-111. Published online March 31, 2020; DOI: https://doi.org/10.23876/j.krcp.19.082
Web of Science 8 Cited By 11; Full text PubReader PDF

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond: Patrick Biggar, Gheun-Ho Kim; Kidney Res Clin Pract. 2017;36(3):209-223. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.209
Web of Science 26 Cited By 25; Full text PubReader PDF

Posterior nutcracker phenomenon with Down syndrome: Eun Sil Koh, Min Young Kim, Yoon Sik Chang, Sungjin Chung; Kidney Res Clin Pract. 2015;34(4):245-246. Published online November 12, 2015; DOI: https://doi.org/10.1016/j.krcp.2015.10.001
Web of Science 2 Cited By 3; Full text PubReader PDF

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients: Mi Yeon Jung, Soon Young Hwang, Yu Ah Hong et al.; Kidney Res Clin Pract. 2015;34(1):20-27. Published online January 15, 2015; DOI: https://doi.org/10.1016/j.krcp.2014.11.003
Web of Science 9 Cited By 9; Full text PubReader PDF

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis: Ha-Young Na, Yong-Kyu Lee, Sug-Kyun Shin et al.; Kidney Res Clin Pract. 2014;33(4):210-216. Published online December 5, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.10.001
Web of Science 1 Cited By 2; Full text PubReader PDF

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease: Derek S. Larson, Daniel W. Coyne; Kidney Res Clin Pract. 2013;32(1):11-15. Published online January 16, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.01.001
Cited By 16; Full text PubReader PDF

14,675	Role of urate transporters in the kidneys and intestine in uric acid homeostasis
10,868	Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients
10,154	Baseline characteristics and associated factors for hypertension in children with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Pediatric Chronic Kidney Disease study
9,649	Renal fibrosis: research progress on mechanisms and therapeutic strategies
7,341	Medical treatment for diabetic acute kidney disease from 2012 to 2024: advances, prescription trends, and future directions

Cited By 31	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
Cited By 23	Sarcopenia, sarcopenic obesity, and frailty in individuals with chronic kidney disease: a comprehensive review
Cited By 20	Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Cited By 18	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 17	Role of urate transporters in the kidneys and intestine in uric acid homeostasis

Search